A new study conducted by the World Health Organization (WHO) suggests that in addition to providing significant improvements in public health, investment in the diagnosis and prevention of ...

Produced by the National Institute of Allergy and Infectious Diseases (NIAID), this digitally colorized scanning electron microscopic (SEM) image, depicts a grouping of red-colored, rod shaped, ...

Bacille Calmette-Guérin (BCG) revaccination didn't help prevent sustained Mycobacterium tuberculosis infection in initially uninfected adolescents without HIV in a randomized trial from South Africa.

Prescribing information and clinical guidelines showed gaps in TB screening protocols for many recently approved targeted ...

Despite efforts to eliminate the disease, 13 million Americans are living with latent tuberculosis infection, according to the most recent statistics from the National Health and Nutrition Examination ...

Dolutegravir-based ART with isoniazid was safe and effective for tuberculosis prevention in ART-naïve HIV patients, leading to rapid viral suppression. The study reported minimal adverse events, with ...

Global progress to reduce the number of people who fall ill with tuberculosis (TB) has stalled. More than 10 million people are still getting sick every year, and the COVID-19 pandemic overwhelmed ...

U.S. health officials say they have found a far simpler therapy for people at risk of developing tuberculosis, addressing a key barrier to preventing the spread of the disease. Patients who took a ...

TB remains the leading cause of death among people living with HIV. Uganda is a high TB-burden country, and HIV accelerates ...

New guidelines update ART choices, endorse long-acting injectables, refine infant feeding advice, and prioritise shorter TB ...

TACOMA, Wash. — A Tacoma woman ordered by the court to isolate at home for treatment of tuberculosis (TB) is no longer infectious and free to end isolation and electronic monitoring. The update from ...